Article info

Download PDFPDF
Extended report
Decrease in immunoglobulin free light chains in patients with rheumatoid arthritis upon rituximab (anti-CD20) treatment correlates with decrease in disease activity
  1. Correspondence to Frank A Redegeld, Division of Pharmacology and Pathophysiology, Utrecht Institute for Pharmaceutical Sciences, Sorbonnelaan 16, 3584CA Utrecht, The Netherlands; f.a.m.redegeld{at}uu.nl
View Full Text

Citation

Kormelink TG, Tekstra J, Thurlings RM, et al
Decrease in immunoglobulin free light chains in patients with rheumatoid arthritis upon rituximab (anti-CD20) treatment correlates with decrease in disease activity

Publication history

  • Accepted June 19, 2010
  • First published August 2, 2010.
Online issue publication 
November 19, 2010

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.